Ahvie Herskowitz, MD
With over four decades of experience in Medicine, Cardiology, Immunology, Regenerative Medicine, and Pathology, Dr. Ahvie Herskowitz is one of most senior academic, anti-aging doctors in the US.
Dr. Herskowitz is a former Clinical Professor of Medicine at UC San Francisco (UCSF) and is Founder of Anatara Medicine, a multidisciplinary integrative center in San Francisco.
His training includes a medical degree from The Albert Einstein College of Medicine, residencies in Anatomic Pathology and Internal Medicine, and fellowship training in Cardiology at The Johns Hopkins Medical Center. During his 12 years at Johns Hopkins, he was co-appointed in the Departments of Medicine and Molecular Immunology and Microbiology. His clinical responsibilities were complemented by directing a multidisciplinary NIH-sponsored research team in the study of molecular and immunological mechanisms of heart ischemia, transplantation, heart failure, myocarditis, and cardiac autoimmunity.
Dr. Herskowitz served as Director at the Ischemia Research and Education Foundation, working with over 100 leading heart surgery hospitals around the world, dedicated to reducing adverse outcomes during and after heart surgery. In 2001, he co-founded The Institute for OneWorld Health, the first non-profit pharmaceutical company in the United States, dedicated to developing new medicines for diseases of poverty in the developing world. Throughout his career, Dr. Herskowitz has been developing novel alternative approaches towards health.
He is the current President of the American College for Advancement in Medicine (ACAM), one of the oldest and most respected Integrative Medical Societies in the USA; Chairman of the Board of Directors for iRND3, an organization that discovers new medicines for rare and neglected diseases and serves on the Board for Pulmonary Vascular Research Institute (PVRInstitute).
In 2010, he formed Anatara Medicine, based in San Francisco, to provide a world-class integrative medicine team approach towards prevention and treatment of immunologic, and difficult chronic diseases, such as cancer, chronic infections, and genetic disorders. As Founder of Anatara Medicine, he leads a team of dedicated staff and senior advisors advancing new approaches to personalized and proactive medicine based on the convergence of seven vital disciplines.